TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

Neal D Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.